Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug‐resistant focal epilepsy
Epilepsia Open · 2026-08 · 11 (4) · 1171-1183
DOI: 10.1002/epi4.70255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, online erschienen am 14.05.2026. Verfasst von Silvano R Gefferie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Drug Resistant Epilepsy, Epilepsies, Partial, Anticonvulsants. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anna Teding van Berkhout Stichting, Health-Holland, Top Sector Life Sciences & Health, Netherlands Organisation for Health Research and Development (ZonMW).
Abstract (Originalsprache)
Objective
Cenobamate (CNB) is an effective antiseizure medication, though its mechanisms of efficacy remain incompletely understood. We assessed changes in cortical responses to transcranial magnetic stimulation (TMS) following CNB treatment.
Methods
We recruited people with drug‐resistant focal epilepsy scheduled to start add‐on CNB in a tertiary epilepsy center. We performed TMS coupled with electromyography (EMG) and electroencephalography (EEG) at baseline, at 100 mg/day and at the maximum tolerated or minimum effective dose. Participants were categorized as responders (≥50% seizure reduction) or nonresponders. We used linear mixed models and cluster‐based permutation tests to assess CNB effects on resting motor thresholds (rMTs), intracortical inhibition and the amplitude, mean field power and event‐related spectral perturbation of TMS‐evoked EEG potentials (TEPs). For TMS measures that were significantly affected by CNB dose ( p < 0.05), we assessed differences between responders and non‐responders and correlations with seizure frequency.
Results
Twenty‐eight participants completed the study (16 females; median age, 50 years). rMT ( p < 0.01) increased and cortical silent period (CSP) lengthened ( p = 0.03) with increasing CNB dose. These changes did not differ between responders and nonresponders, nor did they correlate with reduced seizure frequency. Short‐ and long‐interval intracortical inhibition, as well as all TEP parameters, remained unchanged.
Conclusion
While CSP lengthening may merely reflect higher stimulation intensities, rMT increases align with CNB's suggested modulation of sodium channels. Significance rMT changes that are independent of clinical response suggest that sodium channel effects do not fully account for the therapeutic efficacy of CNB. Plain Language Summary We used magnetic brain stimulation in people with epilepsy to find out how the antiseizure medication cenobamate affects brain activity. As its dose increased, cenobamate raised the stimulation strength required to activate a muscle, known as the resting motor threshold (rMT). These changes did not predict a reduction in seizures. This suggests that cenobamate's effectiveness involves more than its effects on mechanisms linked to the rMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands.
- Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands.
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
- Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
- Department of Human Genetics, Leiden University Medical Centre, Leiden, Netherlands.
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Silvano R Gefferie, Diego Jiménez-Jiménez, Gerhard H Visser, Robert M Helling, Josemir W Sander, Simona Balestrini, Roland D Thijs
Förderung
- Anna Teding van Berkhout Stichting
- Health-Holland, Top Sector Life Sciences & Health, Netherlands Organisation for Health Research and Development (ZonMW)
Zitieren
APA
Gefferie, S. R., Jiménez-Jiménez, D., Visser, G. H., Helling, R. M., van den Maagdenberg, A. M. J. M., Sander, J. W., Balestrini, S., & Thijs, R. D. (2026). Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug‐resistant focal epilepsy. Epilepsia Open, 11(4), 1171-1183. https://doi.org/10.1002/epi4.70255
Vancouver
Gefferie SR, Jiménez-Jiménez D, Visser GH, Helling RM, van den Maagdenberg AMJM, Sander JW, et al. Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug‐resistant focal epilepsy. Epilepsia Open. 2026;11(4):1171-1183. doi:10.1002/epi4.70255
BibTeX
@article{Gefferie2026,
author = {Gefferie, Silvano R and Jiménez-Jiménez, Diego and Visser, Gerhard H and Helling, Robert M and van den Maagdenberg, Arn M J M and Sander, Josemir W and Balestrini, Simona and Thijs, Roland D},
title = {Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug‐resistant focal epilepsy},
journal = {Epilepsia Open},
year = {2026},
volume = {11},
number = {4},
pages = {1171--1183},
doi = {10.1002/epi4.70255}
}
EUVIMED